Skip to main content

Table 2 The clinical characteristics of all MDS patients

From: Clinical significance of hyaluronan levels and its pro-osteogenic effect on mesenchymal stromal cells in myelodysplastic syndromes

Characteristics

Values

Tested patients (n)

82

Median age (range)

58 (21–83)

 Sex, n (%)

  Male

42 (51)

  Female

40 (49)

 WHO 2016 classification, n (%)

  MDS-SLD

8 10)

  MDS-RS

4 (5)

  MDS-MLD

40 (49)

  MDS-EB-1

17 (20)

  MDS-EB-2

13 (16)

 IPSS risk groups, n (%)

  Low

5 (6)

  Intermediate-1

54 (66)

  Lower-risk

59 (72)

  Intermediate-2

20 (24)

  High

3 (4)

  Higher-risk

23 (28)

 Karyotypes by IPSS, n (%)

  Good

54 (66)

  Intermediate

15 (18)

  Poor

13 (16)

  1. WHO World Health Organization, MDS myelodysplastic syndrome, SLD single lineage dysplasia, RS ring sideroblasts, MLD multilineage dysplasia, EB excess of blasts, IPSS International Prognostic Scoring System